Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.leukres.2006.02.026
Title: Molecular response of leukemia HL-60 cells to genistein treatment, a proteomics study
Authors: Zhang, D. 
Koay, E.S.-C. 
Tai, Y.-C. 
Wong, C.-H.S.
Chen, C.-S. 
Tai, L.-K. 
Keywords: Cell cycle arrest
Genistein
Leukemia HL-60
Proteomics
Tyrosine kinase
Issue Date: 2007
Source: Zhang, D., Koay, E.S.-C., Tai, Y.-C., Wong, C.-H.S., Chen, C.-S., Tai, L.-K. (2007). Molecular response of leukemia HL-60 cells to genistein treatment, a proteomics study. Leukemia Research 31 (1) : 75-82. ScholarBank@NUS Repository. https://doi.org/10.1016/j.leukres.2006.02.026
Abstract: Genistein (GEN) is a natural protein tyrosine kinase inhibitor. We analyzed the molecular response of HL-60 cells to GEN treatment by gel-based proteomics approach. Fourteen differentially expressed proteins which are functionally involved in metabolism, cell signaling, RNA processing, cell proliferation and motility, and chaperones were identified. Both the dose- and time-dependent up-regulation of Hsp70 protein 8 and heterogeneous nuclear ribonucleoprotein (hnRNP) H1, and the down-regulation of Rab14, hnRNP C and stathmin-1 by GEN were verified by immunoblot analysis. Our novel findings provide insightful clues to the potential therapeutic targets for leukemia treatment in diverse tyrosine kinase-dependent cellular pathways. © 2006 Elsevier Ltd. All rights reserved.
Source Title: Leukemia Research
URI: http://scholarbank.nus.edu.sg/handle/10635/33168
ISSN: 01452126
DOI: 10.1016/j.leukres.2006.02.026
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

20
checked on Dec 6, 2017

WEB OF SCIENCETM
Citations

13
checked on Nov 20, 2017

Page view(s)

109
checked on Dec 10, 2017

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.